litlas
ログインアカウント作成

Andrew Spencer

1986–2025 年に発表

189
論文数
32,616
被引用数
89
h 指数
176
i10 指数

被引用数

Andrew Spencer の年別被引用数1948 年: 被引用 1 件1978 年: 被引用 1 件1988 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 1 件1993 年: 被引用 5 件1994 年: 被引用 1 件1995 年: 被引用 12 件1996 年: 被引用 14 件1997 年: 被引用 23 件1998 年: 被引用 21 件1999 年: 被引用 45 件2000 年: 被引用 68 件2001 年: 被引用 57 件2002 年: 被引用 51 件2003 年: 被引用 79 件2004 年: 被引用 87 件2005 年: 被引用 82 件2006 年: 被引用 90 件2007 年: 被引用 89 件2008 年: 被引用 100 件2009 年: 被引用 146 件2010 年: 被引用 148 件2011 年: 被引用 164 件2012 年: 被引用 129 件2013 年: 被引用 150 件2014 年: 被引用 164 件2015 年: 被引用 180 件2016 年: 被引用 215 件2017 年: 被引用 295 件2018 年: 被引用 245 件2019 年: 被引用 940 件2020 年: 被引用 1,172 件2021 年: 被引用 1,228 件2022 年: 被引用 886 件2023 年: 被引用 729 件2024 年: 被引用 1,277 件2025 年: 被引用 582 件2026 年: 被引用 19 件1949〜1977 年は被引用が無いため表示していません1979〜1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,062 件、この内訳の 24.2%中国: 引用元論文 879 件、この内訳の 6.9%イギリス: 引用元論文 788 件、この内訳の 6.2%ドイツ: 引用元論文 773 件、この内訳の 6.1%イタリア: 引用元論文 712 件、この内訳の 5.6%フランス: 引用元論文 668 件、この内訳の 5.3%スペイン: 引用元論文 569 件、この内訳の 4.5%オーストラリア: 引用元論文 433 件、この内訳の 3.4%カナダ: 引用元論文 416 件、この内訳の 3.3%オランダ: 引用元論文 388 件、この内訳の 3.1%日本: 引用元論文 339 件、この内訳の 2.7%ギリシャ: 引用元論文 306 件、この内訳の 2.4%
0%24.2%その他 26.3%

機関

分野

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Immunology and Microbiology2.5%
  • Arts and Humanities2.3%
  • Computer Science2.1%
  • Engineering1.9%
  • その他4.8%

トピック

  • Multiple Myeloma Research and Treatments14.3%
  • Protein Degradation and Inhibitors7.2%
  • Peptidase Inhibition and Analysis3.9%
  • CAR-T cell therapy research3.4%
  • Cancer Treatment and Pharmacology2%
  • Ubiquitin and proteasome pathways1.9%
  • その他67.3%

共著者

全論文

検索で開く
  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    著者: Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 被引用: 2,995

  2. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

    著者: Jesús F. San Miguel, Binod Dhakal, Kwee Yong, Andrew Spencer, Sébastien Anguille, María‐Victoria Mateos, Carlos Fernández de Larrea, Joaquín Martínez‐López, Philippe Moreau, Cyrille Touzeau, Xavier Leleu, Irit Avivi, Michèle Cavo, Tadao Ishida, Seok Jin Kim, Wilfried Roeloffzen, Niels W.C.J. van de Donk, Dominik Dytfeld, Surbhi Sidana, Luciano J. Costa, Albert Oriol, Rakesh Popat, Abdullah Khan, Yaël C. Cohen, P. Joy Ho, James E. Griffin, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Jordan M. Schecter, Carolyn C. Jackson, Kaitlyn Connors, Katherine Li, Enrique Zudaire, Diana Chen, Jane Gilbert, Tzu‐Min Yeh, Sarah Nagle, Erika Florendo, Lida Pacaud, Nitin Patel, Simon J. Harrison, Hermann Einsele - New England Journal of Medicine 2023 被引用: 733

  3. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    著者: Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, Henk M. Lokhorst, Hartmut Goldschmidt, Laura Rosiñol, Paul Richardson, S Caltagirone, Juan José Lahuerta, Thierry Façon, Sara Bringhen, Francesca Gay, Michel Attal, Roberto Passera, Andrew Spencer, Massimo Offidani, Shaji Kumar, Pellegrino Musto, Sagar Lonial, Maria Teresa Petrucci, Robert Z. Orlowski, Elena Zamagni, Gareth J. Morgan, Meletios Α. Dimopoulos, Brian G.M. Durie, Kenneth C. Anderson, Pieter Sonneveld, Jesús F. San Miguel, Michèle Cavo, S. Vincent Rajkumar, Philippe Moreau - Journal of Clinical Oncology 2015 被引用: 2,178

  4. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau - New England Journal of Medicine 2023 被引用: 515

  5. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

    著者: Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, Ivan Špıčka, Vânia Hungria, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Ming Qi, Jordan M. Schecter, Himal Amin, Xiang Qin, William Deraedt, Tahamtan Ahmadi, Andrew Spencer, Pieter Sonneveld - New England Journal of Medicine 2016 被引用: 1,513

  6. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  7. Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

    著者: Suzanne Trudel, Adam D. Cohen, Amrita Krishnan, Rafaël Fonseca, Andrew Spencer, Jesús G. Berdeja, Alexander M. Lesokhin, Peter A. Forsberg, Jacob P. Laubach, Luciano J. Costa, Paula Rodríguez‐Otero, Rayan Kaedbey, Joshua Richter, María‐Victoria Mateos, Sheeba K. Thomas, Chihunt Wong, Mengsong Li, Voleak Choeurng, Anjali Vaze, Divya Samineni, Teiko Sumiyoshi, James Cooper, Simon J. Harrison - Blood 2021 被引用: 161

  8. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    著者: Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson - New England Journal of Medicine 2015 被引用: 1,320

  9. BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

    著者: Simon J. Hogg, Stephin J. Vervoort, Sumit Deswal, Christopher J. Ott, Jason Li, Leonie A. Cluse, Paul A. Beavis, Phillip K. Darcy, Benjamin Martin, Andrew Spencer, Anna K. Traunbauer, Irina Sadovnik, Karin Bauer, Peter Valent, James E. Bradner, Johannes Zuber, Jake Shortt, Ricky W. Johnstone - Cell Reports 2017 被引用: 300

  10. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

    著者: Simon J. Hogg, Olga Motorna, Leonie A. Cluse, Timothy M. Johanson, Hannah D. Coughlan, Ramya Raviram, Robert M. Myers, Matteo Costacurta, Izabela Todorovski, Lizzy Pijpers, Stefan Bjelosevic, Tobias Williams, Shannon N. Huskins, Conor J. Kearney, Jennifer R. Devlin, Zheng Fan, Jafar S. Jabbari, Ben P. Martin, Mohamed Fareh, Madison J. Kelly, Daphné Dupéré-Richer, Jarrod J. Sandow, Breon Feran, Deborah A. Knight, Tiffany Khong, Andrew Spencer, Simon J. Harrison, Gareth P. Gregory, Vihandha O. Wickramasinghe, Andrew I. Webb, Phillippa C. Taberlay, Kenneth D. Bromberg, Albert Lai, Anthony T. Papenfuss, Gordon K. Smyth, Rhys S. Allan, Jonathan D. Licht, Dan A. Landau, Omar Abdel‐Wahab, Jake Shortt, Stephin J. Vervoort, Ricky W. Johnstone - Molecular Cell 2021 被引用: 170

  11. 3D spatiotemporally scalable in vivo neural probes based on fluorinated elastomers

    著者: Paul Le Floch, Siyuan Zhao, Ren Liu, Nicola Molinari, Eder Medina, Hao Shen, Zheliang Wang, Junsoo Kim, Hao Sheng, Sebastian Partarrieu, Wenbo Wang, Chanan D. Sessler, Guogao Zhang, Hyunsu Park, Xian Gong, Andrew Spencer, Jongha Lee, Tianyang Ye, Xin Tang, Xiao Wang, Katia Bertoldi, Nanshu Lu, Boris Kozinsky, Zhigang Suo, Jia Liu - Nature Nanotechnology 2023 被引用: 100

  12. Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study

    著者: Alexander M. Lesokhin, Joshua Richter, Suzanne Trudel, Adam D. Cohen, Andrew Spencer, Peter A. Forsberg, Jacob P. Laubach, Sheeba K. Thomas, Nizar J. Bahlis, Luciano J. Costa, Paula Rodríguez‐Otero, María‐Victoria Mateos, Jesús G. Berdeja, Rayan Kaedbey, Amrita Krishnan, Rafaël Fonseca, Voleak Choeurng, James Fenimore Cooper, Teiko Sumiyoshi, Chihunt Wong, Simon J. Harrison - Blood 2022 被引用: 75

  13. Targeting MCL-1 in hematologic malignancies: Rationale and progress

    著者: Andrew H. Wei, Andrew W. Roberts, Andrew Spencer, Aaron S. Rosenberg, David S. Siegel, Roland B. Walter, Sean Caenepeel, Paul E. Hughes, Zach McIver, Khalid Mezzi, Phuong K. Morrow, Anthony S. Stein - Blood Reviews 2020 被引用: 210

  14. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    著者: Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Α. Dimopoulos, Luca Dozza, Bronno van der Holt, Sonja Zweegman, Stefania Oliva, Vincent H. J. van der Velden, Elena Zamagni, Giuseppe A. Palumbo, Francesca Patriarca, Vittorio Montefusco, Mónica Galli, Vladimír Maisnar, Barbara Gamberi, Markus Hansson, Angelo Belotti, Luděk Pour, Paula F. Ypma, Mariella Grasso, Alexsandra Croockewit, Stelvio Ballanti, Massimo Offidani, Iolanda Donatella Vincelli, Renato Zambello, Anna Marina Liberati, Niels Frost Andersen, Annemiek Broijl, Rossella Troia, Anna Pascarella, Giulia Benevolo, Mark‐David Levin, Gerard M.J. Bos, Heinz Ludwig, Sara Aquino, Anna Morelli, Ka Lung Wu, Rinske Boersma, Roman Hájek, Marc Durian, Peter A. von dem Borne, Tommaso Caravita di Toritto, Thilo Zander, Christoph Driessen, Giorgina Specchia, Anders Waage, Peter Gimsing, Ulf‐Henrik Mellqvist, Marinus van Marwijk Kooy, Monique C. Minnema, Caroline M.P.W. Mandigers, Anna Maria Cafro, Angelo Palmas, Susanna Carvalho, Andrew Spencer, Mario Boccadoro, Pieter Sonneveld - The Lancet Haematology 2020 被引用: 384

  15. Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

    著者: Pieter Sonneveld, Asher Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, Ivan Špıčka, Vânia Hungria, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Mark‐David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer - Journal of Clinical Oncology 2022 被引用: 120

  16. Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

    著者: David H. Henry, Luís Costa, François Goldwasser, Vera Hirsh, Vânia Hungria, Jana Prausová, Giorgio V. Scagliotti, H.P. Sleeboom, Andrew Spencer, Saroj Vadhan‐Raj, Roger von Moos, Wolfgang Willenbacher, Penella J. Woll, Jianming Wang, Qi Jiang, Susie Jun, Roger Dansey, Howard Yeh - Journal of Clinical Oncology 2011 被引用: 1,262

  17. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    著者: Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Luděk Pour, Roman Hájek, Thierry Façon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, Laura Rosiñol, Jan Štraub, Aleksandr Suvorov, Carla Araujo, Elena Rimashevskaya, Tomáš Pika, Gianluca Gaïdano, Katja Weisel, Vesselina Goranova‐Marinova, Anthony P. Schwarer, Leonard Minuk, Tamás Masszi, Ievgenii Karamanesht, Massimo Offidani, Vânia Hungria, Andrew Spencer, Robert Z. Orlowski, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Wee Joo Chng - The Lancet Oncology 2015 被引用: 849

  18. Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment

    著者: Antonia Reale, Tiffany Khong, Andrew Spencer - Journal of Clinical Medicine 2022 被引用: 48

  19. Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA

    著者: Michèle Cavo, Jesús F. San Miguel, Saad Z. Usmani, Katja Weisel, Meletios Α. Dimopoulos, Hervé Avet‐Loiseau, Bruno Paiva, Nizar J. Bahlis, Torben Plesner, Vânia Hungria, Philippe Moreau, María‐Victoria Mateos, Aurore Perrot, Shinsuke Iida, Thierry Façon, Shaji Kumar, Niels W.C.J. van de Donk, Pieter Sonneveld, Andrew Spencer, Maria Krevvata, Christoph Heuck, Jianping Wang, Jon Ukropec, Rachel Kobos, Steven Sun, Mia Qi, Nikhil C. Munshi - Blood 2021 被引用: 99

  20. TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

    著者: Simone A. Minnie, Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R.W. Legg, Melissa Comstock, Julie R. Boiko, Ethan Nelson, Shruti S. Bhise, Alec B. Wilkens, Motoko Koyama, Madhav V. Dhodapkar, Marta Chesi, Stanley R. Riddell, Damian J. Green, Andrew Spencer, Scott N. Furlan, Geoffrey R. Hill - Science Immunology 2024 被引用: 47

  21. Bioprinting of a Cell-Laden Conductive Hydrogel Composite

    著者: Andrew Spencer, Ehsan Shirzaei Sani, Jonathan R. Soucy, Carolyn C. Corbet, Asel Primbetova, Ryan A. Koppes, Nasim Annabi - ACS Applied Materials & Interfaces 2019 被引用: 167

  22. Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study

    著者: Emma Searle, Hang Quach, Sandy W. Wong, Luciano J. Costa, Cyrille Hulin, Wojciech Janowski, Jesús G. Berdeja, Sébastien Anguille, Jeffrey Matous, Cyrille Touzeau, Anne‐Sophie Michallet, Marla Husnik, Deeksha Vishwamitra, Zhuolu Niu, Julie S. Larsen, Ling‐Ling Chen, Jenna D. Goldberg, Rakesh Popat, Andrew Spencer - Blood 2022 被引用: 60

  23. Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

    著者: Anne Gulbins, Mareike Horstmann, Anke Daser, Ulrich Flögel, Michael Oeverhaus, Nikolaos E. Bechrakis, J. Paul Banga, Simone Keitsch, Barbara Wilker, Gerd Krause, Gary D. Hammer, Andrew Spencer, Ryan K. Zeidan, Anja Eckstein, Svenja Philipp, Gina-Eva Görtz - Frontiers in Endocrinology 2023 被引用: 49

  24. Human‐Recombinant‐Elastin‐Based Bioinks for 3D Bioprinting of Vascularized Soft Tissues

    著者: Sohyung Lee, Ehsan Shirzaei Sani, Andrew Spencer, Yvonne Guan, Anthony S. Weiss, Nasim Annabi - Advanced Materials 2020 被引用: 159